<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chen Y</submitter><funding>Top Talent Support Program for young and middle-aged people of Wuxi Health Committee</funding><funding>China Postdoctoral Science Foundation</funding><pagination>458</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12008863</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) plays a vital role in angiogenesis, when its nucleic acid-binding domain is occupied by transthyretin (TTR), the neovascularization of human retinal microvascular endothelial cells (hRECs) is repressed under hyperglycemic conditions.&lt;h4>Methods&lt;/h4>HnRNPA2B1-targeting peptides (THIPs) were designed based on the core fragments at the TTR-hnRNPA2B1 interface. Biacore, Langmuir equilibrium adsorption, and co-immunoprecipitation (co-IP) assays were performed to determine the association between the THIPs and hnRNPA2B1. Proliferation and DNA synthesis in hRECs were detected using CCK-8 and EdU assays. Transwell, wound healing, and tube formation assays were used to evaluate migratory and the angiogenic capacity of hRECs</pubmed_abstract><journal>Journal of translational medicine</journal><pubmed_title>Peptides based on the interface of hnRNPA2B1-transthyretin complex repress retinal angiogenesis in diabetic retinopathy.</pubmed_title><pmcid>PMC12008863</pmcid><funding_grant_id>2020M671541</funding_grant_id><funding_grant_id>BJ2023017</funding_grant_id><pubmed_authors>Ye L</pubmed_authors><pubmed_authors>Shao J</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors><pubmed_authors>Cui S</pubmed_authors><pubmed_authors>Xin Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Peptides based on the interface of hnRNPA2B1-transthyretin complex repress retinal angiogenesis in diabetic retinopathy.</name><description>&lt;h4>Background&lt;/h4>Heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) plays a vital role in angiogenesis, when its nucleic acid-binding domain is occupied by transthyretin (TTR), the neovascularization of human retinal microvascular endothelial cells (hRECs) is repressed under hyperglycemic conditions.&lt;h4>Methods&lt;/h4>HnRNPA2B1-targeting peptides (THIPs) were designed based on the core fragments at the TTR-hnRNPA2B1 interface. Biacore, Langmuir equilibrium adsorption, and co-immunoprecipitation (co-IP) assays were performed to determine the association between the THIPs and hnRNPA2B1. Proliferation and DNA synthesis in hRECs were detected using CCK-8 and EdU assays. Transwell, wound healing, and tube formation assays were used to evaluate migratory and the angiogenic capacity of hRECs</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Apr</publication><modification>2026-06-01T14:48:02.085Z</modification><creation>2026-04-08T13:29:47.989Z</creation></dates><accession>S-EPMC12008863</accession><cross_references><pubmed>40253339</pubmed><doi>10.1186/s12967-025-06437-y</doi></cross_references></HashMap>